| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Review articles |
Centre de Recherche sur la Fonction, Structure et Ingénierie des Protéines, Pavillon Charles–Eugène Marchand, Biologie Médicale, Faculté de Médecine, Université Laval, Québec G1K 7P4, Canada
Correspondence: R C Levesque. Email: rclevesq{at}rsvs.ulaval.ca
Cystic fibrosis (CF) is caused by a defect in the transmembrane conductance regulator (CFTR) protein that functions as a chloride channel. Dysfunction of the CFTR protein results in salty sweat, pancreatic insufficiency, intestinal obstruction, male infertility and severe pulmonary disease. In most patients with CF life expectancy is limited due to a progressive loss of functional lung tissue. Early in life a persistent neutrophylic inflammation can be demonstrated in the airways. The cause of this inflammation, the role of CFTR and the cause of lung morbidity by different CF-specific bacteria, mostly Pseudomonas aeruginosa, are not well understood. The lack of an appropriate animal model with multi-organ pathology having the characteristics of the human form of CF has hampered our understanding of the pathobiology and chronic lung infections of the disease for many years. This review summarizes the main characteristics of CF and focuses on several available animal models that have been frequently used in CF research. A better understanding of the chronic lung infection caused particularly by P. aeruginosa, the pathophysiology of lung inflammation and the pathogenesis of lung disease necessitates animal models to understand CF, and to develop and improve treatment.
Key Words: Cystic fibrosis animal models chronic lung infection Pseudomonas aeruginosa
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. L. Boulette, P. J. Baynham, P. A. Jorth, I. Kukavica-Ibrulj, A. Longoria, K. Barrera, R. C. Levesque, and M. Whiteley Characterization of Alanine Catabolism in Pseudomonas aeruginosa and Its Importance for Proliferation In Vivo J. Bacteriol., October 15, 2009; 191(20): 6329 - 6334. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tertilt, J. Joh, A. Krause, P. Chou, K. Schneeweiss, R. G. Crystal, and S. Worgall Expression of B-Cell Activating Factor Enhances Protective Immunity of a Vaccine against Pseudomonas aeruginosa Infect. Immun., July 1, 2009; 77(7): 3044 - 3055. [Abstract] [Full Text] [PDF] |
||||